Wellgistics Health will propose renaming itself DataMeds AI and rebranding its pharmacy division as Corexa Health under its planned consolidation with DataVault AI and partners. It has 2,647,198 common shares outstanding, with 1,333,930 locked for 90 days, 919,465 tradable via DTCC and 80,628 warrants exercisable at $35.
Wellgistics Health’s board has selected DataMeds AI, Inc. as its new corporate name, subject to shareholder approval via a preliminary proxy filed June 18. The stock ticker is expected to remain MEDS, reflecting the company’s shift toward an integrated AI-driven healthcare ecosystem.
The company reports 2,647,198 common shares outstanding, of which 1,333,930 are subject to a 90-day lock-up. Additionally, 919,465 shares are deposited in DTCC and available for trading, and 80,628 cash warrants are exercisable at a fixed $35 per share.
Wellgistics Health has entered into a fully binding letter of intent with DataVault AI, Scilex Pharma, EOS Technology Holdings and HealthBridge Advisors to form DataMeds AI. The parties anticipate completing the transaction in the third quarter of 2026, pending customary closing conditions and approvals.
The company’s Pharmacy and Pharmacy Services division will be renamed Corexa Health as it expands EinsteinRx AI into medical, laboratory and wearable data segments. This rebranding aligns with the Health Lives Here app’s blockchain-enabled platform to give patients control and monetization opportunities for their health data.
